These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 10428103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.
    Moore JP, Ho DD.
    J Virol; 1993 Feb; 67(2):863-75. PubMed ID: 7678308
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autoantibodies to the alpha/beta T-cell receptors in human immunodeficiency virus infection: dysregulation and mimicry.
    Lake DF, Schluter SF, Wang E, Bernstein RM, Edmundson AB, Marchalonis JJ.
    Proc Natl Acad Sci U S A; 1994 Nov 08; 91(23):10849-53. PubMed ID: 7971973
    [Abstract] [Full Text] [Related]

  • 6. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F, Bergami PL, Duval M, Kuhrt D, Posner M, Cavacini L.
    AIDS Res Hum Retroviruses; 2003 Jul 08; 19(7):597-607. PubMed ID: 12908937
    [Abstract] [Full Text] [Related]

  • 7. Anti-IgG autoantibodies in HIV-infected hemophilia patients.
    Süsal C, Lewin IV, Stanworth DR, Terness P, Daniel V, Oberg HH, Huth-Kühne A, Zimmermann R, Opelz G.
    Vox Sang; 1992 Jul 08; 62(4):224-9. PubMed ID: 1642003
    [Abstract] [Full Text] [Related]

  • 8. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD, Bruce CB, Featherstone AS, Downing RG, Biryahawaho B, Clegg JC, Carswell JW, Oram JD.
    AIDS Res Hum Retroviruses; 1994 May 08; 10(5):577-83. PubMed ID: 7522494
    [Abstract] [Full Text] [Related]

  • 9. Immunoglobulin-like domain of HIV-1 envelope glycoprotein gp120 encodes putative internal image of some common human proteins.
    Metlas R, Skerl V, Veljkovic V, Colombatti A, Pongor S.
    Viral Immunol; 1994 May 08; 7(4):215-9. PubMed ID: 7576036
    [Abstract] [Full Text] [Related]

  • 10. Correlation between anti-V3 peptide and neutralizing antibodies in plasma from HIV-1 infected individuals resident in Brazil.
    Bongertz V, Morgado MG, Galvão-Castro B, Wigzell H, Hendry RM.
    Mem Inst Oswaldo Cruz; 1994 May 08; 89(1):113-4. PubMed ID: 7823807
    [Abstract] [Full Text] [Related]

  • 11. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
    Connelly RJ, Kahn M, Blake J, Haffar OK, Thomas EK.
    Virology; 1994 Dec 08; 205(2):554-7. PubMed ID: 7526543
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals.
    Hariharan K, Nara PL, Caralli VM, Norton FL, Haigwood N, Kang CY.
    J Virol; 1993 Feb 08; 67(2):953-60. PubMed ID: 7678311
    [Abstract] [Full Text] [Related]

  • 13. The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain.
    Schreiber M, Wachsmuth C, Müller H, Odemuyiwa S, Schmitz H, Meyer S, Meyer B, Schneider-Mergener J.
    J Virol; 1997 Dec 08; 71(12):9198-205. PubMed ID: 9371578
    [Abstract] [Full Text] [Related]

  • 14. Molecular localization of human IgG anti-F(ab')2 reactivity with variable- and constant-region lambda light-chain epitopes.
    Williams RC, Malone CC, Silvestris F, Solomon A.
    J Clin Immunol; 1995 Nov 08; 15(6):349-62. PubMed ID: 8576321
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual.
    Torán JL, Kremer L, Sánchez-Pulido L, de Alborán IM, del Real G, Llorente M, Valencia A, de Mon MA, Martínez-A C.
    Eur J Immunol; 1999 Sep 08; 29(9):2666-75. PubMed ID: 10508241
    [Abstract] [Full Text] [Related]

  • 16. An immunoassay with bovine serum albumin coupled peptides for the improved detection of anti V3 antibodies in HIV-1 positive human sera.
    Gómez CE, López-Campistrous AE, Duarte CA.
    J Virol Methods; 1998 Mar 08; 71(1):7-16. PubMed ID: 9628216
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers.
    Rubinstein A, Goldstein H, Pettoello-Mantovani M, Mizrachi Y, Bloom BR, Furer E, Althaus B, Que JU, Hasler T, Cryz SJ.
    AIDS; 1995 Mar 08; 9(3):243-51. PubMed ID: 7755912
    [Abstract] [Full Text] [Related]

  • 18. The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody.
    Welschof M, Terness P, Kipriyanov SM, Stanescu D, Breitling F, Dörsam H, Dübel S, Little M, Opelz G.
    Proc Natl Acad Sci U S A; 1997 Mar 04; 94(5):1902-7. PubMed ID: 9050877
    [Abstract] [Full Text] [Related]

  • 19. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K, Sällberg M, Sönnerborg A.
    AIDS Res Hum Retroviruses; 1994 Nov 04; 10(11):1551-6. PubMed ID: 7534097
    [Abstract] [Full Text] [Related]

  • 20. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.
    Kozlowski PA, Chen D, Eldridge JH, Jackson S.
    AIDS Res Hum Retroviruses; 1994 Jul 04; 10(7):813-22. PubMed ID: 7986587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.